Business

CSD500 CE Mark

CSD500 CE Mark.

articleFutura Medical PlcJune 20, 20115/company/futura-medical-plc/news/csd500-ce-mark
CSD500 CE Mark

About this update from Futura Medical Plc

[{"type":"text","content":"\n \nRNS Number : 6992I Futura Medical PLC 20 June 2011  \n \n\n \n\n\n\n\nFor immediate release\n\n\n20 June 2011\n\n\n\n\n \n \n \nFutura Medical plc\n(\"Futura\" or \"the Company\")\n \nCSD500 CE mark certification\n \nFutura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, is pleased to announce it has been informed that the relevant Notified Body is satisfied that all outstanding points in the regulatory dossier for CSD500 have been resolved and has been recommended to their Review Panel for approval.  The Panel'sapproval process typically takes a month and is already underway. A further statement will be made in the coming weeks regarding the issueof the CE mark certificate.\nThe CE mark certificate will enable CSD500 to be marketed and sold within 29 European territories and a number of other non-European territories that recognise the CE mark process.  Reckitt Benckiser plc, makers of the Durex® branded condom have exclusive global rights to CSD500.\n \n \nFor any further information please contact:\n \n\n\n\n\nFutura Medical plc\n\n\n \n\n\n\n\nJames Barder, Chief Executive\n\n\nTel: +44 (0) 1483 685 670\n\n\n\n\n \n\n\n \n\n\n\n\nmail to: [email protected]\n\n\nwww.futuramedical.com\n\n\n\n\n \n\n\n \n\n\n\n\nNomura Code Securities Limited\n\n\n \n\n\n\n\nPhil Walker / Giles Balleny\n\n\nTel:+44 (0)20 7776 1200\n\n\n\n\n \n\n\n \n\n\n\n\nFor media enquiries please contact:\n\n\n \n\n\n\n\n \n\n\n \n\n\n\n\nBuchanan Communications\n\n\n \n\n\n\n\nMark Court / Jessica Fontaine\n\n\nTel: +44 (0) 20 7466 5000\n\n\n\n\n \n \nNotes to Editors\n \nFutura Medical plc\n \nFutura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.\n \nFutura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.\n \nwww.futuramedical.com \n \n \n \n \n\nThis information is provided by RNSThe company news service from the London Stock Exchange  END  ...

More updates from Futura Medical Plc